CoChat
Sign Up
Cited by 168Cell death mechanisms and regulationMitochondrial Function and PathologyCardiac Ischemia and Reperfusion

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Voltage-dependent Anion Channel 1-based Peptides Interact with Bcl-2 to Prevent Antiapoptotic Activity

Open access
Arbel, Nir, Shoshan-Barmatz, Varda·2010·Journal of Biological Chemistry
DOI 10.1074/jbc.m109.082990PMC PMC2825399
Open this paper in CoChat — free accountOpen PDF

Abstract

The antiapoptotic proteins of the Bcl-2 family are expressed at high levels in many types of cancer. However, the mechanism by which Bcl-2 family proteins regulate apoptosis is not fully understood. Here, we demonstrate the interaction of Bcl-2 with the outer mitochondrial membrane protein, voltage-dependent anion channel 1 (VDAC1). A direct interaction of Bcl-2 with bilayer-reconstituted purified VDAC was demonstrated, with Bcl-2 decreasing channel conductance. Expression of Bcl-2-GFP prevented apoptosis in cells expressing native but not certain VDAC1 mutants. VDAC1 sequences and amino acid residues important for interaction with Bcl-2 were defined through site-directed mutagenesis. Synthetic peptides corresponding to the VDAC1 N-terminal region and selected sequences bound specifically, in a concentration- and time-dependent manner, to immobilized Bcl-2, as revealed by the real-time surface plasmon resonance. Moreover, expression of the VDAC1-based peptides in cells over-expressing Bcl-2 prevented Bcl-2-mediated protection against staurosporine-induced apoptotic cell death. Similarly, a cell-permeable VDAC1-based synthetic peptide was also found to prevent Bcl-2-GFP-mediated protection against apoptosis. These results point to Bcl-2 as promoting tumor cell survival through binding to VDAC1, thereby inhibiting cytochrome c release and apoptotic cell death. Moreover, these findings suggest that interfering with the binding of Bcl-2 to mitochondria by VDAC1-based peptides may serve to potentiate the efficacy of conventional chemotherapeutic agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m109.082990

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE1 Bcl-2( 𝚫 C23)reducesbilayer-reconstituted VDAC conductance. A , VDAC was reconstituted into a PLB and current in response to a voltage step from 0 to -10 mV was recorded 2 and 25 min after the addition of purified Bcl-2( 𝚫 C23) (1 nM). Thereafter, the voltage was switched for 2 to -60 mV, and current was recorded at -10 mV (total incubation time with Bcl-2( 𝚫 C23) was 32 min). B , VDAC was reconstituted into a PLB, and currents through VDAC in response to a voltage step from 0 to -10 mV were recorded before and 15 min after the addition of purified Bcl-2( 𝚫 C23) (1 nM) and after exposing the protein to high negative voltage for 2-3 min. Following current recording, the cis compartment was perfused to highly decrease the concentration of Bcl2( 𝚫 C23) by severalfold. The dashed lines indicate the zero current levels. C , shown are multichannel recordings as a function of the voltage (4 s at each voltage), and the average steady-state conductance of mVDAC1 before ( F ) and 30 min after ( E ) the addition of Bcl-2( 𝚫 C23) (1 nM) and after exchanging the solution with Bcl-2( 𝚫 C23)free medium ( , ) are presented. Relative conductance was determined as the ratio of the conductance at a given voltage ( G ) to the maximal conductance ( Go ). D , a Coomassie-stained purified VDAC and Bcl-2 proteins are shown.
FIGURE1 Bcl-2( 𝚫 C23)reducesbilayer-reconstituted VDAC conductance. A , VDAC was reconstituted into a PLB and current in response to a voltage step from 0 to -10 mV was recorded 2 and 25 min after the addition of purified Bcl-2( 𝚫 C23) (1 nM). Thereafter, the voltage was switched for 2 to -60 mV, and current was recorded at -10 mV (total incubation time with Bcl-2( 𝚫 C23) was 32 min). B , VDAC was reconstituted into a PLB, and currents through VDAC in response to a voltage step from 0 to -10 mV were recorded before and 15 min after the addition of purified Bcl-2( 𝚫 C23) (1 nM) and after exposing the protein to high negative voltage for 2-3 min. Following current recording, the cis compartment was perfused to highly decrease the concentration of Bcl2( 𝚫 C23) by severalfold. The dashed lines indicate the zero current levels. C , shown are multichannel recordings as a function of the voltage (4 s at each voltage), and the average steady-state conductance of mVDAC1 before ( F ) and 30 min after ( E ) the addition of Bcl-2( 𝚫 C23) (1 nM) and after exchanging the solution with Bcl-2( 𝚫 C23)free medium ( , ) are presented. Relative conductance was determined as the ratio of the conductance at a given voltage ( G ) to the maximal conductance ( Go ). D , a Coomassie-stained purified VDAC and Bcl-2 proteins are shown.CC-BY · From the PDF
Image 2
CC-BY · From the PDF
FIGURE 3 Overexpression of Bcl-2 protects against apoptosis induced by STS in T-REx-293 cells overexpressing native mVDAC1 but not E65Q-, E72Q-orE202Q-mVDAC1mutants. shRNA-T-Rex-293 cells were transiently cotransfected with plasmids pEGFP-Bcl-2 or pEGFP and pcDNA4/TO, respectively, encoding native, E65Q-, E72Q-, or E202Q-mVDAC1 (or pcDNA4/TO as control) and grown for 48 h in the presence of tetracycline (1 𝛍 g/ml, to induce expression) prior to exposure to STS (1.25 𝛍 M) for 4 h. Apoptosis was quantitatively analyzed by acridine orange/ethidium bromide staining. Data represent mean values ± S.E. ( n = 3).
FIGURE 3 Overexpression of Bcl-2 protects against apoptosis induced by STS in T-REx-293 cells overexpressing native mVDAC1 but not E65Q-, E72Q-orE202Q-mVDAC1mutants. shRNA-T-Rex-293 cells were transiently cotransfected with plasmids pEGFP-Bcl-2 or pEGFP and pcDNA4/TO, respectively, encoding native, E65Q-, E72Q-, or E202Q-mVDAC1 (or pcDNA4/TO as control) and grown for 48 h in the presence of tetracycline (1 𝛍 g/ml, to induce expression) prior to exposure to STS (1.25 𝛍 M) for 4 h. Apoptosis was quantitatively analyzed by acridine orange/ethidium bromide staining. Data represent mean values ± S.E. ( n = 3).CC-BY · From the PDF
Image 4
CC-BY · From the PDF
FIGURE 5 Expression of VDAC1-based peptides in T-Rex-293 cells prevented Bcl-2-mediated protection against cell death induced by STS. T-REx-293 cells were transfected to express Bcl-2 and/or the indicated VDAC1-based peptide designed according to the original (AP, Trp 63 -Asn 78 ; BP, Pro 105 -Lys 119 ; CP, Glu 117 Thr 134 ; BP, Pro 105 -Lys 119 ) ( A ) or newly proposed (L4-5, Thr 71 -Leu 80 ; L14-15, Leu 207 -Arg 217 ; L16-17, Lys 235 Gln 248 ) and (L18-19, Leu 262 -His 272 ) ( B ) VDAC1transmembranetopologymodels.VDAC1-basedpeptideexpression was induced by tetracycline (1.5 𝛍 g/ml). Apoptosis in the different cell types was induced by incubation with STS (1.25 𝛍 M, 4 h) and quantitatively analyzed by acridine orange/ethidium bromide staining. Data represent mean ± S.E. ( n = 3). N-ter , N-terminal.
FIGURE 5 Expression of VDAC1-based peptides in T-Rex-293 cells prevented Bcl-2-mediated protection against cell death induced by STS. T-REx-293 cells were transfected to express Bcl-2 and/or the indicated VDAC1-based peptide designed according to the original (AP, Trp 63 -Asn 78 ; BP, Pro 105 -Lys 119 ; CP, Glu 117 Thr 134 ; BP, Pro 105 -Lys 119 ) ( A ) or newly proposed (L4-5, Thr 71 -Leu 80 ; L14-15, Leu 207 -Arg 217 ; L16-17, Lys 235 Gln 248 ) and (L18-19, Leu 262 -His 272 ) ( B ) VDAC1transmembranetopologymodels.VDAC1-basedpeptideexpression was induced by tetracycline (1.5 𝛍 g/ml). Apoptosis in the different cell types was induced by incubation with STS (1.25 𝛍 M, 4 h) and quantitatively analyzed by acridine orange/ethidium bromide staining. Data represent mean ± S.E. ( n = 3). N-ter , N-terminal.CC-BY · From the PDF
Image 6
CC-BY · From the PDF
FIGURE 6 Selected VDAC1-based peptides interact with Bcl-2( 𝚫 C23 ) in a specific and dose-dependent manner. Interaction of purified Bcl-2( 𝚫 C23) with VDAC1-based peptides was revealed using real-time SPR. Bcl-2 immobilized onto a GLM sensor surface was exposed to VDAC1-based peptides: A , AP (Trp 63 -Asn 78 ; 50, 100, and 200 𝛍 M); B , BP (Pro 105 -Lys 119 ; 50, 100, and 200 𝛍 M); C , CP (Glu 117 -Thr 134 ; 50, 100, and 200 𝛍 M); D , DP (Lys 199 -Asn 215 ; 50, 100, and 200 𝛍 M); and E , N-terminal domain (Met 1 -Phe 25 ; 50, 100, and 200 𝛍 M). To control for nonspecific binding, the interaction of the N-terminal peptide ( N-ter ; F , 200 𝛍 M) with surface strips of IgG was analyzed. The peptides were run in parallel over surface strips of Bcl-2( 𝚫 C23) and responses (resonance units, RU ) as a function of peptide concentration were monitored using the ProteOn imaging system and related software tools. All experiments were carried out at 25 °C.
FIGURE 6 Selected VDAC1-based peptides interact with Bcl-2( 𝚫 C23 ) in a specific and dose-dependent manner. Interaction of purified Bcl-2( 𝚫 C23) with VDAC1-based peptides was revealed using real-time SPR. Bcl-2 immobilized onto a GLM sensor surface was exposed to VDAC1-based peptides: A , AP (Trp 63 -Asn 78 ; 50, 100, and 200 𝛍 M); B , BP (Pro 105 -Lys 119 ; 50, 100, and 200 𝛍 M); C , CP (Glu 117 -Thr 134 ; 50, 100, and 200 𝛍 M); D , DP (Lys 199 -Asn 215 ; 50, 100, and 200 𝛍 M); and E , N-terminal domain (Met 1 -Phe 25 ; 50, 100, and 200 𝛍 M). To control for nonspecific binding, the interaction of the N-terminal peptide ( N-ter ; F , 200 𝛍 M) with surface strips of IgG was analyzed. The peptides were run in parallel over surface strips of Bcl-2( 𝚫 C23) and responses (resonance units, RU ) as a function of peptide concentration were monitored using the ProteOn imaging system and related software tools. All experiments were carried out at 25 °C.CC-BY · From the PDF
Image 8
CC-BY · From the PDF
Image 9
CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 4

  1. Krajewski, 1993, Cancer Res., 53, 4701
  2. De Pinto, 2003, Ital. J. Biochem., 52, 17
  3. Dias, 2002, Mol. Cancer Ther., 1, 347
  4. Leone, 2003, Cancer Res., 63, 8118

Cited by

Sorted by citations

See all 168

Related

Metadata

Authors
Arbel, N., & Shoshan-Barmatz, V.
Affiliations
Ben-Gurion University of the Negev (IL)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2010-02
Volume
285
Issue
9
Pages
6053-6062
ISSN
0021-9258 (ISSN-L)
DOI
10.1074/jbc.m109.082990
PMC
PMC2825399
OpenAlex
W1998225262
Cited by
168
References
68
Citations by year
2026: 5 · 2025: 8 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 11 · 2020: 14 · 2019: 8 · 2018: 18 · 2017: 18 · 2016: 11 · 2015: 9 · 2014: 15 · 2013: 9 · 2012: 11
FWCI
2.82
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Israel Science Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
Keywords
VDAC1, Bcl-2, Bcl-2 family proteins, apoptosis, anti-apoptotic effects, mitochondrial outer membrane, cytochrome c release, staurosporine-induced apoptosis, tumor cell survival, chemosensitization, channel conductance
MeSH terms
Animals, Cell Line, Electric Conductivity, Electrophysiology, Humans, Mitochondria, Peptide Fragments, Protein Binding, Sheep, Mutagenesis, Site-Directed, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Surface Plasmon Resonance, Voltage-Dependent Anion Channel 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review